| Literature DB >> 34976092 |
Hui Wang1,2, Jingjing Cui1, Shitong Zhao3, Dongsheng Xu1, Shuang Wu1, Wanzhu Bai1, Jia Wang1.
Abstract
OBJECTIVE: To collect and summarize relevant literatures on the experimental researches of sciatic nerve injury (SNI) with acupuncture during the last decade providing a guideline for effectively treating SNI with acupuncture in the future.Entities:
Year: 2021 PMID: 34976092 PMCID: PMC8718293 DOI: 10.1155/2021/1401756
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Publication status of experimental research of SNI with acupuncture during 2009–2020.
Figure 2Animal application status in experimental research of SNI with acupuncture.
Figure 3The intervention application status in experimental research of SNI with acupuncture. Note. EA: electroacupuncture; MA: manual acupuncture; AA: ankle acupuncture; SA: scalp acupuncture.
Figure 4The acupoint selection in experimental research of SNI with acupuncture.
Figure 5The meridians selection in experimental research of SNI with acupuncture. Note. GB: gallbladder meridian; ST: stomach meridian; BL: bladder meridian; SP: spleen meridian; LR: liver meridian.
Figure 6The detailed measurements and indicators in the experimental research of SNI with acupuncture. Note: AchE: acetylcholinesterase; bcl-2: b cell lymphoma-2; BDNF: brain-derived neurotrophic factor; bFGF: basic fibroblast growth factor; Cdc42: cell division cycle 42; CNTF: ciliary neurotrophic factor; CSPGs: chondroitin sulfate proteoglycans; GAP-43: growth-associated protein-43; IGF-1: insulin-like growth factor 1; IL-1β: interleukin-1 beta; IL-6: interleukin 6; MAG: myelin-associated glycoprotein; NADH-TR: nicotinomide adenine dinucleotide dehydrogenase-tetrazolium reductase; NCAM: neural cell adhesion molecule; NF-kB: nuclear factor kB; NGF: nerve growth factor; NT3: neurotrophin-3; nNOS: neuronal nitric oxide synthase; SLIT 1/2: slit guidance ligand 1/2; SP: substance P; TNF-α: tumor necrosis factor-α; Trkc: tropomyosin receptor kinase C; VEGF: vascular endothelial growth factor.
Summary table showing the application characteristics of acupuncture on SNI.
| Treatment strategy | Selected acupoints | Treatment frequency | Treatment course | Stimulation parameters of EA | Analysis methods | Detailed molecules or factors | |||
|---|---|---|---|---|---|---|---|---|---|
| Waveform | Frequency | Current or voltage | Time of treatment | ||||||
| EA (93.3%) | Huantiao (GB30, 66.3%) | Once per day (97.7%); | >2 W (56.2%); | Dilatational wave (64.5%) | 2/100 Hz (64.5%); | Cause mild muscle tremor (84.2%); 1.5 mA (3.9%) | 20 min (36.25%); | ① Behavioral measurement (SFI, pain threshold, toe abduction reflex, and inclined pulling test); | ① Growth factor and neurotrophic factors (NGF, bFGF, BDNF, CNTF, IGF-1, SLIT 1/2, Netrin-1) |
Note. EA: electroacupuncture; MA: manual acupuncture; AA: ankle acupuncture; SA: scalp acupuncture; W: week; AchE: acetylcholinesterase; bcl-2: b cell lymphoma-2; BDNF: brain-derived neurotrophic factor; bFGF: basic fibroblast growth factor; Cdc42: cell division cycle 42; CNTF: ciliary neurotrophic factor; CSPGs: chondroitin sulfate proteoglycans; GAP-43: growth-associated protein-43; IGF-1: insulin-like growth factor 1; IL-1β: interleukin-1 beta; IL-6: interleukin 6; MAG: myelin-associated glycoprotein; NADH-TR: nicotinomide adenine dinucleotide dehydrogenase-tetrazolium reductase; NCAM: neural cell adhesion molecule; NF-kB: nuclear factor kB; NGF: nerve growth factor; NT3: neurotrophin-3; nNOS: neuronal nitric oxide synthase; SLIT 1/2: slit guidance ligand 1/2; SP: substance P; TNF-α: tumor necrosis factor-α; Trkc: tropomyosin receptor kinase C; VEGF: vascular endothelial growth factor.